#esmo21 highlights on mfs analysis from comb. treatments in high-risk adv. prostate cancer: stampede
Published 2 years ago • 1.5K plays • Length 2:45Download video MP4
Download video MP3
Similar videos
-
4:33
#esmo21 expert video report on prostate cancer
-
1:19
highlights in prostate cancer from esmo
-
2:19
#esmo21 highlights on pembrolizumab in fully resected high-risk stage ii melanoma: keynote-716 study
-
28:31
prostate cancer highlights from esmo 2022
-
6:41
esmo expert report on combination therapy in advanced prostate cancer @ asco gu 2022
-
0:52
clinical trial updates in prostate cancer at esmo 2022
-
2:26
#esmo21 highlights on pembro chemo in 1st-line metastatic cervical cancer: the keynote-826 study
-
3:18
#esmo21 highlights on combination of pembrolizumab plus chemotherapy in mtnbc: the keynote-355 study
-
3:09
#esmo21 highlights on nivo ipi vs extreme in 1st-line high-risk scchn: the checkmate 651 study
-
2:18
#esmo21 highlights on maintenance olaparib in ovarian cancer previously treated with parpi
-
0:56
gu summary for esmo 2023 | dr. rana mckay | oncology brothers #oncology
-
3:25
highlights on lu-psma-617 in taxane-naive patients with mcrpc: the psmafore study
-
1:35
#esmo21 highlights on a phase i of dual raf/mek inhibitor fak inhibitor in ovarian cancer (frame)
-
7:08
expert video report on prostate cancer from 2021 genitourinary cancers symposium
-
8:51
esmo 2020 expert video report on precision medicine in prostate cancer
-
2:47
#esmo21 highlights on erdafitinib in adv. urothelial cancer with fgfra alterations: the norse study
-
1:41
#esmo21 highlights on nivolumab in pretreated thymoma & thymic carcinoma: eortc-etop nivothym study